Proven Efficacy
With 10 years on the market and prescribed for nearly 24 million patients worldwide, ZYPREXA® (olanzapine) offers you dependable control of the symptoms of schizophrenia and acute manic and mixed episodes of bipolar I disorder.
Connecting with your patient and using your skills and professional training to help him or her move forward in life is the goal of every treatment team member. ZYPREXA helps you achieve these goals.
Patients Treated With ZYPREXA for Schizophrenia:
- Experienced improvement in positive symptoms
- Experienced early and robust improvement in depressive symptoms
- Demonstrated significantly lower discontinuation rates
- Experienced fewer hospitalizations
- Demonstrated improvement in work status
Patients Treated With ZYPREXA for Bipolar Disorder:
- Demonstrated rapid improvement in symptoms of mixed and manic episodes of bipolar disorder as early as the first week of treatment
- Experienced a significant delay in relapse (patients with mixed episodes)
